Therotepa 15mg Injection

About

Therotepa 15mg Injection contains thiotepa, an alkylating agent used in chemotherapy. It works by forming covalent bonds with DNA, leading to cross-linking of DNA strands and inhibition of DNA, RNA, and protein synthesis. This action is profoundly cytotoxic, primarily affecting rapidly dividing cells, including cancer cells. Thiotepa is a broad-spectrum antineoplastic agent, often employed in high-dose chemotherapy regimens with hematopoietic stem cell support, particularly in conditioning regimens prior to bone marrow transplantation. It is also used for intracavitary administration in certain cancers, such as bladder cancer, and for systemic treatment of breast and ovarian cancers. Its mechanism disrupts cellular replication, ultimately leading to cell death and tumor regression.

Uses

• High-dose chemotherapy with hematopoietic stem cell support.
• Treatment of bladder cancer (intravesical administration).
• Management of breast cancer.
• Treatment of ovarian cancer.

Directions For Use

Administered intravenously, intravesically, or intracavitary by a healthcare professional. Dosage and schedule vary based on indication and patient factors.

Benefits

• Potent cytotoxic agent against various cancers.
• Effective in high-dose chemotherapy regimens.
• Can be administered via multiple routes.
• Part of established cancer treatment protocols.
• May improve disease-free survival in specific settings.
• Useful for both systemic and localized therapy.

Side Effects

• Myelosuppression (severe, dose-limiting).
• Nausea.
• Vomiting.
• Mucositis.
• Alopecia.
• Skin reactions (e.g., hyperpigmentation).
• Fatigue.
• Anorexia.
• Hepatotoxicity.
• Renal dysfunction.
• Neurotoxicity (rare).
• Secondary malignancies (long-term risk).

Safety Measures

• Alcohol - Avoid alcohol consumption during treatment, as it can exacerbate gastrointestinal side effects and potentially increase liver toxicity.
• Pregnancy - Contraindicated during pregnancy. Thiotepa is genotoxic and teratogenic. Women of childbearing potential must use effective contraception.
• Breastfeeding - Contraindicated. Thiotepa is excreted in breast milk and can cause serious adverse effects in infants. Breastfeeding must be discontinued.
• Liver - Use with extreme caution in patients with hepatic impairment. Dose adjustment may be necessary, and liver function should be closely monitored.
• Kidney - Use with caution in patients with renal impairment. Dose adjustment may be required, and renal function should be monitored due to potential nephrotoxicity.
• Lung - Use with caution. Pulmonary toxicity, including interstitial pneumonitis, has been reported, though rarely. Monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.